U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

During your visit, your healthcare professional will likely review your medical history, perform a physical exam, and discuss your current lifestyle to determine whether Wegovy is right for you.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Wegovy may significantly reduce hospital admissions for any cause and overall length of stay, according to a new analysis of data from Novo Nordisk's phase 3 SELECT trial.

In addition, the American Gastroenterological Association includes Wegovy in its treatment recommendations for obesity. A large review of studies compared GLP-1 agonist medications, including ...

One shipment of suspected counterfeit Wegovy was hidden inside a Mickey Mouse puzzle for ... users to verify if a website selling medications has been vetted. You can also review a list of the current ...

A Novo Nordisk trial also discovered an association between Wegovy prescriptions and fewer hospitalizations for any cause. In the study, 33.4% of patients taking Wegovy were admitted, compared to ...

Fifty years ago, 20 of the world's brightest people tried to predict life in 2024. They got an awful lot wrong.

If you’re considering a semaglutide medication like Ozempic or Wegovy for weight loss, you may be a bit worried about the ...

Wegovy (semaglutide) is an injectable medication ... Semaglutide for the treatment of overweight and obesity: A review. Diabetes Obes Metab. 2023;25(1):18-35. doi:10.1111/dom.